Principal Financial Group’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Sell |
8,612
-460,949
| -98% | -$15M | ﹤0.01% | 2083 |
|
|
2025
Q1 | $17.7M | Buy |
469,561
+160,622
| +52% | +$6.07M | 0.01% | 907 |
|
|
2024
Q4 | $25.3M | Buy |
308,939
+256,237
| +486% | +$21M | 0.01% | 723 |
|
|
2024
Q3 | $6.02M | Buy |
52,702
+34,287
| +186% | +$3.92M | ﹤0.01% | 1499 |
|
|
2024
Q2 | $1.39M | Sell |
18,415
-6,182
| -25% | -$467K | ﹤0.01% | 1818 |
|
|
2024
Q1 | $1.68M | Buy |
24,597
+2,589
| +12% | +$177K | ﹤0.01% | 1800 |
|
|
2023
Q4 | $1.38M | Buy |
22,008
+376
| +2% | +$23.6K | ﹤0.01% | 1802 |
|
|
2023
Q3 | $1.1M | Sell |
21,632
-524
| -2% | -$26.7K | ﹤0.01% | 1828 |
|
|
2023
Q2 | $1.11M | Buy |
22,156
+4,848
| +28% | +$242K | ﹤0.01% | 1831 |
|
|
2023
Q1 | $649K | Sell |
17,308
-1,154
| -6% | -$43.3K | ﹤0.01% | 1917 |
|
|
2022
Q4 | $885K | Buy |
18,462
+4,190
| +29% | +$201K | ﹤0.01% | 1875 |
|
|
2022
Q3 | $342K | Sell |
14,272
-225
| -2% | -$5.39K | ﹤0.01% | 2046 |
|
|
2022
Q2 | $315K | Buy |
+14,497
| New | +$315K | ﹤0.01% | 2163 |
|
|
2021
Q4 | – | Sell |
-10,121
| Closed | -$257K | – | 2600 |
|
|
2021
Q3 | $257K | Sell |
10,121
-1,641
| -14% | -$41.7K | ﹤0.01% | 2349 |
|
|
2021
Q2 | $265K | Buy |
11,762
+448
| +4% | +$10.1K | ﹤0.01% | 2400 |
|
|
2021
Q1 | $223K | Buy |
11,314
+797
| +8% | +$15.7K | ﹤0.01% | 2354 |
|
|
2020
Q4 | $279K | Buy |
+10,517
| New | +$279K | ﹤0.01% | 2252 |
|